GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] proposal — a flair for half-life posts — 59 comments in the full submission. View in context.
4.9k
c/glp1science·submitted 1 year ago by u/nadia_bakker

[Meta] proposal — a flair for half-life posts

Speculationbranch of 7 comments

Putting this to the board: proposal — a flair for half-life posts. Why mechanism talk keeps misleading people, including me. A mechanism tells you a direction. It does not tell you a magnitude, a timescale, or whether the pathway is operative at the exposures involved. "Receptor X is expressed in tissue Y" is a fact;…

Read the full submission and all 59 comments →

This branch

7 comments, started 1 year ago
u/annika_fonseca373 points·1 year ago

Receptor expression in a tissue is necessary but not sufficient for an effect. You also need the agonist to reach it at relevant exposure, and that is where a lot of confident mechanism talk falls down.

replysharereportpermalink
u/nadia_bakkerOP0 points·1 year ago

Correction: that is glucose-dependent insulin secretion, which is why hypoglycaemia risk is low as monotherapy. Not the same claim as you made.

replysharereportpermalink
u/nadia_bakkerOP270 points·1 year ago

Receptor expression in a tissue is necessary but not sufficient for an effect.

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

replysharereportpermalink
u/zeynep_villalobos183 points·1 year ago·edited

That study was in a rodent model. Worth stating, since the thread has been reading it as human data.

replysharereportpermalink
u/priya_guerrero129 points·1 year ago

Was completely wrong about the gastric emptying story in a thread here two years ago. Someone corrected me with a citation and I have not made that mistake since.

replysharereportpermalink
u/nadia_fonseca81 points·1 year ago

mechanism explains a direction, not a magnitude

replysharereportpermalink
u/aleksi_lehtinen67 points·1 year ago

The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.